» Articles » PMID: 28608985

Statistical Performance of Image Cytometry for DNA, Lipids, Cytokeratin, & CD45 in a Model System for Circulation Tumor Cell Detection

Overview
Journal Cytometry A
Specialties Cell Biology
Radiology
Date 2017 Jun 14
PMID 28608985
Authors
Affiliations
Soon will be listed here.
Abstract

Detection of circulating tumor cells (CTCs) in a blood sample is limited by the sensitivity and specificity of the biomarker panel used to identify CTCs over other blood cells. In this work, we present Bayesian theory that shows how test sensitivity and specificity set the rarity of cell that a test can detect. We perform our calculation of sensitivity and specificity on our image cytometry biomarker panel by testing on pure disease positive (D ) populations (MCF7 cells) and pure disease negative populations (D ) (leukocytes). In this system, we performed multi-channel confocal fluorescence microscopy to image biomarkers of DNA, lipids, CD45, and Cytokeratin. Using custom software, we segmented our confocal images into regions of interest consisting of individual cells and computed the image metrics of total signal, second spatial moment, spatial frequency second moment, and the product of the spatial-spatial frequency moments. We present our analysis of these 16 features. The best performing of the 16 features produced an average separation of three standard deviations between D and D and an average detectable rarity of ∼1 in 200. We performed multivariable regression and feature selection to combine multiple features for increased performance and showed an average separation of seven standard deviations between the D and D populations making our average detectable rarity of ∼1 in 480. Histograms and receiver operating characteristics (ROC) curves for these features and regressions are presented. We conclude that simple regression analysis holds promise to further improve the separation of rare cells in cytometry applications. © 2017 International Society for Advancement of Cytometry.

References
1.
Potcoava M, Futia G, Aughenbaugh J, Schlaepfer I, Gibson E . Raman and coherent anti-Stokes Raman scattering microscopy studies of changes in lipid content and composition in hormone-treated breast and prostate cancer cells. J Biomed Opt. 2014; 19(11):111605. PMC: 4059341. DOI: 10.1117/1.JBO.19.11.111605. View

2.
He W, Kularatne S, Kalli K, Prendergast F, Amato R, Klee G . Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands. Int J Cancer. 2008; 123(8):1968-73. PMC: 2778289. DOI: 10.1002/ijc.23717. View

3.
Scholtens T, Schreuder F, Ligthart S, Swennenhuis J, Greve J, Terstappen L . Automated identification of circulating tumor cells by image cytometry. Cytometry A. 2011; 81(2):138-48. DOI: 10.1002/cyto.a.22002. View

4.
Racila E, Euhus D, Weiss A, Rao C, McConnell J, Terstappen L . Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci U S A. 1998; 95(8):4589-94. PMC: 22534. DOI: 10.1073/pnas.95.8.4589. View

5.
Piyathilake C, Frost A, Manne U, Bell W, Weiss H, Heimburger D . The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum Pathol. 2000; 31(9):1068-73. DOI: 10.1053/hupa.2000.9842. View